1.
Influence of concurrent capecitabine based chemoradiotherapy with bevacizumab on the survival rate, late toxicity and health- related quality life in locally advanced rectal cancer. A prospective phase II CRAB trial. Radiol Oncol. 2020;54(4):461-469. Accessed October 22, 2026. https://www.radioloncol.com/index.php/ro/article/view/3424